Loading...
Gastric cancer: toward a cisplatin-free disease?
Historically, the cornerstone of treatment of advanced gastric cancer (GC) is 5-fluorouracil (5-FU)-based chemotherapy that increases median overall survival (OS) compared to best supportive care by some months. The addition of cisplatin (CDDP) to chemotherapy doublets showed a limited but significa...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Artigo |
Language: | Inglês |
Published: |
Pioneer Bioscience Publishing Company
2014
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4110503/ https://ncbi.nlm.nih.gov/pubmed/25083304 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2078-6891.2014.022 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|